年別の研究成果
年別の研究成果
検索結果
-
2022
Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy
Hongo, H., Kosaka, T., Hayashi, H., Nakamura, K., Nishihara, H., Mikami, S., Beltran, H. & Oya, M., 2022 1月 1, In: Asian Journal of Andrology. 24, 1, p. 116-118 3 p.研究成果: Letter › 査読
Open Access2 被引用数 (Scopus) -
Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma
Shigeta, K., Matsumoto, K. & Oya, M., 2022 1月, In: European Urology. 81, 1, p. e20-e21研究成果: Letter › 査読
-
2016
Syndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide
Yanai, Y., Matsumoto, K., Niwa, N., Kosaka, T., Kikuchi, E., Miyajima, A., Ito, H. & Oya, M., 2016 1月 1, In: Acta Oncologica. 55, 3, p. 399-400 2 p.研究成果: Letter › 査読
1 被引用数 (Scopus) -
2014
Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor
Mizuno, R., Miyajima, A. & Oya, M., 2014 7月, In: International Journal of Urology. 21, 7, p. 740 1 p.研究成果: Letter › 査読
1 被引用数 (Scopus)